Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults

Adverse drug events (ADEs) represent an expensive societal burden that disproportionally affects older adults. Therefore, value-based organizations that provide care to older adults—such as the Program of All-Inclusive Care for the Elderly (PACE)—should be highly motivated to identify actual or pote...

Full description

Bibliographic Details
Main Authors: Hubert Jin, Sue Yang, David Bankes, Stephanie Finnel, Jacques Turgeon, Alan Stein
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/10/3/551
_version_ 1797471244641107968
author Hubert Jin
Sue Yang
David Bankes
Stephanie Finnel
Jacques Turgeon
Alan Stein
author_facet Hubert Jin
Sue Yang
David Bankes
Stephanie Finnel
Jacques Turgeon
Alan Stein
author_sort Hubert Jin
collection DOAJ
description Adverse drug events (ADEs) represent an expensive societal burden that disproportionally affects older adults. Therefore, value-based organizations that provide care to older adults—such as the Program of All-Inclusive Care for the Elderly (PACE)—should be highly motivated to identify actual or potential ADEs to mitigate risks and avoid downstream costs. We sought to determine whether PACE participants receiving medication risk mitigation (MRM) services exhibit improvements in total healthcare costs and other outcomes compared to participants not receiving structured MRM. Data from 2545 PACE participants from 19 centers were obtained for the years 2018 and 2019. We compared the year-over-year changes in outcomes between patients not receiving (control) or receiving structured MRM services. Data were adjusted based on participant multimorbidity and geographic location. Our analyses demonstrate that costs in the MRM cohort exhibited a significantly smaller year-to-year increase compared to the control (MRM: USD 4386/participant/year [95% CI, USD 3040–5732] vs. no MRM: USD 9410/participant/year [95% CI, USD 7737–11,084]). Therefore, receipt of structured MRM services reduced total healthcare costs (<i>p</i> < 0.001) by USD 5024 per participant from 2018 to 2019. The large majority (75.8%) of the reduction involved facility-related expenditures (e.g., hospital admission, emergency department visits, skilled nursing). In sum, our findings suggest that structured MRM services can curb growing year-over-year healthcare costs for PACE participants.
first_indexed 2024-03-09T19:46:24Z
format Article
id doaj.art-750e55e66cc84901854e3a9184063cee
institution Directory Open Access Journal
issn 2227-9032
language English
last_indexed 2024-03-09T19:46:24Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Healthcare
spelling doaj.art-750e55e66cc84901854e3a9184063cee2023-11-24T01:23:20ZengMDPI AGHealthcare2227-90322022-03-0110355110.3390/healthcare10030551Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older AdultsHubert Jin0Sue Yang1David Bankes2Stephanie Finnel3Jacques Turgeon4Alan Stein5Office of Healthcare Analytics, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAOffice of Healthcare Analytics, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAOffice of Translational Research and Residency Programs, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAOffice of Healthcare Analytics, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAPrecision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Lake Nona, Orlando, FL 32827, USAOffice of Healthcare Analytics, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAAdverse drug events (ADEs) represent an expensive societal burden that disproportionally affects older adults. Therefore, value-based organizations that provide care to older adults—such as the Program of All-Inclusive Care for the Elderly (PACE)—should be highly motivated to identify actual or potential ADEs to mitigate risks and avoid downstream costs. We sought to determine whether PACE participants receiving medication risk mitigation (MRM) services exhibit improvements in total healthcare costs and other outcomes compared to participants not receiving structured MRM. Data from 2545 PACE participants from 19 centers were obtained for the years 2018 and 2019. We compared the year-over-year changes in outcomes between patients not receiving (control) or receiving structured MRM services. Data were adjusted based on participant multimorbidity and geographic location. Our analyses demonstrate that costs in the MRM cohort exhibited a significantly smaller year-to-year increase compared to the control (MRM: USD 4386/participant/year [95% CI, USD 3040–5732] vs. no MRM: USD 9410/participant/year [95% CI, USD 7737–11,084]). Therefore, receipt of structured MRM services reduced total healthcare costs (<i>p</i> < 0.001) by USD 5024 per participant from 2018 to 2019. The large majority (75.8%) of the reduction involved facility-related expenditures (e.g., hospital admission, emergency department visits, skilled nursing). In sum, our findings suggest that structured MRM services can curb growing year-over-year healthcare costs for PACE participants.https://www.mdpi.com/2227-9032/10/3/551Program of All-Inclusive Care for the Elderlyadverse drug eventsmedication-related problemsdrug-related problemspharmacistsmedication safety
spellingShingle Hubert Jin
Sue Yang
David Bankes
Stephanie Finnel
Jacques Turgeon
Alan Stein
Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults
Healthcare
Program of All-Inclusive Care for the Elderly
adverse drug events
medication-related problems
drug-related problems
pharmacists
medication safety
title Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults
title_full Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults
title_fullStr Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults
title_full_unstemmed Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults
title_short Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults
title_sort evaluating the impact of medication risk mitigation services in medically complex older adults
topic Program of All-Inclusive Care for the Elderly
adverse drug events
medication-related problems
drug-related problems
pharmacists
medication safety
url https://www.mdpi.com/2227-9032/10/3/551
work_keys_str_mv AT hubertjin evaluatingtheimpactofmedicationriskmitigationservicesinmedicallycomplexolderadults
AT sueyang evaluatingtheimpactofmedicationriskmitigationservicesinmedicallycomplexolderadults
AT davidbankes evaluatingtheimpactofmedicationriskmitigationservicesinmedicallycomplexolderadults
AT stephaniefinnel evaluatingtheimpactofmedicationriskmitigationservicesinmedicallycomplexolderadults
AT jacquesturgeon evaluatingtheimpactofmedicationriskmitigationservicesinmedicallycomplexolderadults
AT alanstein evaluatingtheimpactofmedicationriskmitigationservicesinmedicallycomplexolderadults